0

Journal Articles

in Health Promotion/Disease Prevention
 181-200 of 658 Articles
JAMA Internal Medicine | 
Review Article |  November 14, 2011 FREE
The Effect of Lifestyle Modification and Cardiovascular Risk Factor Reduction on Erectile Dysfunction:  A Systematic Review and Meta-analysis
Bhanu P. Gupta, MD; M. Hassan Murad, MD; Marisa M. Clifton, MD; et al.
Arch Intern Med. 2011;171(20):1797-1803. doi:10.1001/archinternmed.2011.440.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Editor's Correspondence |  November 08, 2011
Primary Prevention Cardiovascular Disease: Better Than Drugs
John J. Pippin, MD
Arch Intern Med. 2011;170(20):1860-1861. doi:10.1001/archinternmed.2010.402.
JAMA Internal Medicine | 
Editor's Correspondence |  November 08, 2011
Primary Prevention Cardiovascular Disease: Better Than Drugs—Reply
Michel de Lorgeril, MD; Patricia Salen, BSc; Mikael Rabeus, MD
Arch Intern Med. 2011;170(20):1860-1861. doi:10.1001/archinternmed.2010.403.
JAMA Pediatrics | 
Editorial |  November 01, 2011
Translating Cost-effective Injury Prevention Research Into Sustainable Change on the Playing Field:  The Youth Injury Epidemic
M. Alison Brooks, MD, MPH; Timothy A. McGuine, PhD, ATC
Arch Pediatr Adolesc Med. 2011;165(11):1049-1050. doi:10.1001/archpediatrics.2011.174.
JAMA Dermatology | 
Correspondence |  November 01, 2011
Cutaneous Infarction Under IL-12/23 p40 Inhibition: A Cautionary Note
Dan Lipsker, MD, PhD; Virginie Lutz, MD
Arch Dermatol. 2011;147(11):1344-1345. doi:10.1001/archdermatol.2011.318.
JAMA Internal Medicine | 
Invited Commentary |  October 24, 2011
Cardiovascular Risk Stratification, Hemoglobin A1c, and the Tempo of Translation:  Comment on “Cardiovascular Risk Prediction in Diabetic Men and Women Using Hemoglobin A1c vs Diabetes as a High-Risk Equivalent”
Mark J. Pletcher, MD, MPH
Arch Intern Med. 2011;171(19):1718-1720. doi:10.1001/archinternmed.2011.352.
JAMA Internal Medicine | 
Original Investigation |  October 24, 2011 FREE
Cardiovascular Risk Prediction in Diabetic Men and Women Using Hemoglobin A1c vs Diabetes as a High-Risk Equivalent
Nina P. Paynter, PhD; Norman A. Mazer, MD, PhD; Aruna D. Pradhan, MD; et al.
Arch Intern Med. 2011;171(19):1712-1718. doi:10.1001/archinternmed.2011.351.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Editor's Correspondence |  September 12, 2011
The Use of Cognitive Behavioral Therapy for Secondary Prevention in Patients With Coronary Heart Disease
Adrienne E. O'Neil, BA(Hons); Kristy Sanderson, BSc(Hons), PhD
Arch Intern Med. 2011;171(16):1506-1507. doi:10.1001/archinternmed.2011.388.
JAMA Internal Medicine | 
Editor's Correspondence |  September 12, 2011
Hypoglycemia Associated With Impaired Renal Function
Adam M. Ali, BA(Cantab)
Arch Intern Med. 2011;171(16):1512. doi:10.1001/archinternmed.2011.378.
JAMA Internal Medicine | 
Editor's Correspondence |  September 12, 2011
The Use of Cognitive Behavioral Therapy for Secondary Prevention in Patients With Coronary Heart Disease—Reply
Kurt Svärdsudd, MD, PhD; Mats Gulliksson, MD, PhD
Arch Intern Med. 2011;171(16):1506-1507. doi:10.1001/archinternmed.2011.389.
JAMA Internal Medicine | 
Review Article |  September 12, 2011 FREE
Impact of Pharmacist Care in the Management of Cardiovascular Disease Risk Factors:  A Systematic Review and Meta-analysis of Randomized Trials
Valérie Santschi, PharmD, PhD; Arnaud Chiolero, MD, MSc; Bernard Burnand, MD, MPH; et al.
Arch Intern Med. 2011;171(16):1441-1453. doi:10.1001/archinternmed.2011.399.
JAMA Neurology | 
Special Article |  September 01, 2011
Risk Factors and Preventive Interventions for Alzheimer Disease:  State of the Science
Martha L. Daviglus, MD, PhD; Brenda L. Plassman, PhD; Amber Pirzada, MD; et al.
Arch Neurol. 2011;68(9):1185-1190. doi:10.1001/archneurol.2011.100.
JAMA Internal Medicine | 
Invited Commentary |  August 08, 2011
Prevention of Type 2 Diabetes:  Comment on “Lifestyle Modification and Prevention of Type 2 Diabetes in Overweight Japanese With Impaired Fasting Glucose Levels”
William C. Knowler, MD, DrPH
Arch Intern Med. 2011;171(15):1361-1362. doi:10.1001/archinternmed.2011.367.
JAMA Internal Medicine | 
Original Investigation |  August 08, 2011 FREE
Lifestyle Modification and Prevention of Type 2 Diabetes in Overweight Japanese With Impaired Fasting Glucose Levels:  A Randomized Controlled Trial
Toshikazu Saito, MD, PhD; Makoto Watanabe, MD, PhD; Junko Nishida, MD; et al.
Arch Intern Med. 2011;171(15):1352-1360. doi:10.1001/archinternmed.2011.275.
JAMA Pediatrics | 
Advice for Patients |  August 01, 2011 FREE
Breastfeeding as Obesity Prevention
Megan A. Moreno, MD, MSEd, MPH; Fred Furtner; Frederick P. Rivara, MD, MPH
Arch Pediatr Adolesc Med. 2011;165(8):772. doi:10.1001/archpediatrics.2011.140.
JAMA Internal Medicine | 
Correction |  July 25, 2011
Last-minute Change in June 27 Table of Contents
Arch Intern Med. 2011;171(14):1224. doi:10.1001/archinternmed.2011.366.
JAMA | 
Commentary |  June 22, 2011
Vitamin D and Prevention of Cardiovascular Disease and Diabetes:  Why the Evidence Falls Short
Sue A. Shapses, PhD; JoAnn E. Manson, MD, DrPH
JAMA. 2011;305(24):2565-2566. doi:10.1001/jama.2011.881.
JAMA Internal Medicine | 
Review Article |  June 13, 2011 FREE
Influence of Noninvasive Cardiovascular Imaging in Primary Prevention:  Systematic Review and Meta-analysis of Randomized Trials
Daniel G. Hackam, MD, PhD; Kaveh G. Shojania, MD; J. David Spence, MD; et al.
Arch Intern Med. 2011;171(11):977-982. doi:10.1001/archinternmed.2011.69.
JAMA Pediatrics | 
Article |  June 01, 2011 FREE
Effectiveness of a Citywide Patient Immunization Navigator Program on Improving Adolescent Immunizations and Preventive Care Visit Rates
Peter G. Szilagyi, MD, MPH; Sharon G. Humiston, MD, MPH; Sarah Gallivan, MSW, MPH; et al.
Arch Pediatr Adolesc Med. 2011;165(6):547-553. doi:10.1001/archpediatrics.2011.73.
JAMA | 
Commentary |  May 25, 2011
An Opportunity Map for Societal Investment in Health
Jonathan E. Fielding, MD, MPH; Steven M. Teutsch, MD, MPH
JAMA. 2011;305(20):2110-2111. doi:10.1001/jama.2011.698.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
RESEARCH LETTER  |  June 17, 2013
ω-3 Fatty Acid Supplements for Secondary Prevention of Cardiovascular Disease: From “No Proof of Effectiveness” to “Proof of No Effectiveness”
Andrea Messori, PharmD; Valeria Fadda, PharmD; Dario Maratea, PharmD; et al.
JAMA Internal Medicine
Editor's Correspondence  |  June 10, 2013
Noncommunicable Diseases in Developing Countries: Focus on Research Capacity Building
Ayodele Odutayo, BHSc; Naheed Hirji, BASc
JAMA Pediatrics
Correction  |  June 01, 2013
Omission in eTable in: Prevention of Adult Obesity: How Much Weight Change Is Necessary for Normalization of Weight Status in Children?
JAMA Internal Medicine
Research Letters  |  May 13, 2013
Rapid Assessment of Cardiovascular Risk Among Users of Smoking Cessation Drugs Within the US Food and Drug Administration's Mini-Sentinel Program
Sengwee Toh, ScD; Meghan A. Baker, MD, ScD; Jeffrey S. Brown, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems